1. Home
  2. NODK vs FATE Comparison

NODK vs FATE Comparison

Compare NODK & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NODK

NI Holdings Inc.

N/A

Current Price

$14.80

Market Cap

303.2M

Sector

Finance

ML Signal

N/A

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

N/A

Current Price

$0.92

Market Cap

260.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NODK
FATE
Founded
1946
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
303.2M
260.0M
IPO Year
2016
2013

Fundamental Metrics

Financial Performance
Metric
NODK
FATE
Price
$14.80
$0.92
Analyst Decision
Buy
Analyst Count
0
11
Target Price
N/A
★ $5.72
AVG Volume (30 Days)
11.6K
★ 1.6M
Earning Date
11-06-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 29.88
EPS
★ 0.87
N/A
Revenue
★ $285,050,000.00
$6,646,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$18.72
P/E Ratio
$17.01
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$12.37
$0.95
52 Week High
$16.70
$3.23

Technical Indicators

Market Signals
Indicator
NODK
FATE
Relative Strength Index (RSI) 49.95 18.27
Support Level $14.80 N/A
Resistance Level $15.78 $1.38
Average True Range (ATR) 0.49 0.15
MACD -0.04 -0.08
Stochastic Oscillator 33.48 2.18

Price Performance

Historical Comparison
NODK
FATE

About NODK NI Holdings Inc.

NI Holdings Inc is a stockholding company. Through its subsidiaries, the company operates in the insurance industry, offering homeowners and farmowners insurance policies, crop insurance policies, home insurance policies, etc. These insurance products are distributed through a network of exclusive and independent agents across the United States. The group's reportable segments are: Private Passenger Auto, Non-Standard Auto, Home and Farm, Crop, and All Other (which mainly consists of commercial, assumed reinsurance, and its excess liability business). Maximum revenue is generated from the Home and Farm segment.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: